0% found this document useful (0 votes)
11 views8 pages

ALM Guideline Template Ver7.0

This document outlines the guidelines for manuscript submission in various fields of laboratory medicine, including structure, formatting, and ethical considerations. It specifies requirements for abstracts, references, figures, tables, author contributions, conflicts of interest, and research funding. The document emphasizes adherence to ethical standards and provides detailed instructions on citation styles and data presentation.

Uploaded by

Brilliant
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
11 views8 pages

ALM Guideline Template Ver7.0

This document outlines the guidelines for manuscript submission in various fields of laboratory medicine, including structure, formatting, and ethical considerations. It specifies requirements for abstracts, references, figures, tables, author contributions, conflicts of interest, and research funding. The document emphasizes adherence to ethical standards and provides detailed instructions on citation styles and data presentation.

Uploaded by

Brilliant
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 8

1 Type of Manuscript: Guideline

3 Specific Area: Diagnostic Hematology / Clinical Chemistry / Clinical Microbiology /

4 Diagnostic Immunology / Transfusion and Cell Therapy / Diagnostic Genetics / Laboratory

5 Informatics / General Laboratory Medicine

6 (Please select the appropriate area from the above examples.)

8 TITLE:

10 ABSTRACT

11 Structured or unstructured abstract is of no more than 250 words.

12

13 Key Words: Key word 1, Key word 2, Key word 3 [List three to ten pertinent keywords to

14 be adjusted to the Medical Subject Heading (MeSH) of Index Medicus

15 (http://www.nlm.nih.gov/mesh/ MBrowser.html)].

16

1 1
2
17 INTRODUCTION

18 The introduction of the study should provide a concise overview of its context and emphasize

19 its significance. It should clarify the purpose of the work and its importance. A thorough

20 examination of the current state of research in the field should be conducted, with relevant

21 publications being referenced. Briefly mention the main objective of the study and emphasize

22 its principal conclusions at the end. There is no limit of the length of the manuscript.

23

24

25 HEADING 1

26 Sub-heading 1

27 References should be cited numerically in square brackets, such as [1] or [2,3], or as a range

28 [4–6]. The name of a microorganism should be spelled out the first mention in the abstract,

29 and original text. The names of the genus can be abbreviated subsequently (example: E. coli).

30 The names of the genes, and not the proteins should be italicized: BCR-ABL mutations,

31 HER2-positive.

32

33 Sub-heading 2

34 Experiments conducted on human subjects should be performed according to the Declaration

35 of Helsinki https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/) and

36 approved by the Research Ethics Committee or the Institutional Review Board (IRB) of the

37 institution where the experiment was performed. Written informed consent should be

38 obtained from all subjects, when necessary. Statistical methods should be described with

3 2
4
39 software program in detail.

40

41 HEADING 2

42 Sub-heading 1

43 There is no limit of the number of Tables or Figures. All sections of the results should

44 refer to a figure (for example, Fig. 1) or table (for example, Table 1), preferably a data

45 display element that is part of the main text. All figures, figure panels and tables must be

46 presented in order. Figures or tables too large for print, manuscript material that exceeds the

47 limitation for the specific submission type, or appendices should be submitted for online

48 publication only. These files should be marked and uploaded separately as supplemental files

49 during submission and should be referenced within the text as supplemental data (i.e., “See

50 Supplemental Data Table S1”, “See Supplemental Data Figure S1”, etc.).

51

52 Sub-heading 2

53 Equations can be included. Use MathType (recommended) or use the legacy equation editor

54 in Word (Chose Insert > Insert Object > Word Equation). P is the proportion and N is the

55 number of samples.

56

57 ACKNOWLEDGMENTS

58 None

59

5 3
6
60 AUTHOR CONTRIBUTIONS

61 *Individual names are printed by initials (Last name and initials).

62 (Example) Isaac Newton, Newton I; Soo-Youn Lee, Lee SY

63

64 Conceptualization:

65 Methodology:

66 Investigation:

67 Visualization:

68 Funding acquisition:

69 Project administration:

70 Supervision:

71 Writing – original draft:

72 Writing – review & editing:

73

74 CONFLICTS OF INTEREST

75 Include any financial interests for each author that could be perceived as being a conflict of

76 interest (i.g. sources of support, consulting fee or honorarium, support for travel to meetings

77 for the study or other purposes, fee for participation in review activities such as data

78 monitoring boards, payment for writing the manuscript, provision of writing assistance or

79 equipment, board membership, patents, royalties, monetary interests in the products studied,

7 4
8
80 consultantships, stocks, etc.). When authors have no competing interests, this should also be

81 declared (e.g., “None declared.”).

82

83 RESEARCH FUNDING

84 This work was supported by Organization X (Grant No. XXXXX).

85 or None.

86

87 REFERENCES

88 1. Ann Lab Med uses “Vancouver” style, as outlined in the ICMJE sample references.

89 References must be numbered in order of appearance in the text (including citations in

90 tables and legends) and listed individually at the end of the manuscript. There is no limit

91 of the number of References. Each entry starts with the author’s last name and initials.

92 When a source has more than one author, their names are separated by commas. If a

93 source has more than six authors, list the first six followed by ‘et al.’

94 2. Lindberg DA. Collection, evaluation, and transmission of hospital laboratory data.

95 Methods Inf Med 1967;6:97-107.

96 3. Garratty G and Petz LD. Approaches to selecting blood for transfusion to patients

97 with autoimmune hemolytic anemia. Transfusion 2002;42:1390-2.

98 4. Helms CC, Marvel M, Zhao W, Stahle M, Vest R, Kato GJ, et al. Mechanisms of

99 hemolysis-associated platelet activation. J Thromb Haemost 2013;11:2148-54.

100

101

9 5
10
102 Tables

103 Table 1. Short title of the first table

Title 1 Title 2* N (%)

Entry 1† Data‡ 200 (10.0)

Entry 2 Data§ 1,800 (90.0)

*
104 Tables may have footnotes.


105 Tables may have footnotes.


106 Tables may have footnotes.

§
107 Tables may have footnotes.

108 Abbreviations: NT, not tested and SAA, severe aplastic anemia.

109

11 6
12
110 Figures

111

112 Fig. 1. Short title of the figure. (A), explanation and (B), explanation. *P < 0.05, †P < 0.001,

113 ‡not significant.

114 Abbreviations: NT, not tested.

13 7
14
115 Supplemental Data

116

117 Supplemental Data Table S1. Short title of the first table

118

119

120 Supplemental Data Figure S1. Short title of the first figure

15 8
16

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy